Sher, D. J., Henson, J., Avutu, B., Hochberg, F., Batchelor, T., Martuza, R., . . . Chakravarti, A. (2008). The Added Value of Concurrently-Administered Temozolomide Versus Adjuvant Temozolomide Alone in Newly-Diagnosed Glioblastoma.
Chicago Style CitationSher, David J., John Henson, Bindu Avutu, Fred Hochberg, Tracy Batchelor, Robert Martuza, Fred Barker, Jay S. Loeffler, i Arnab Chakravarti. The Added Value of Concurrently-Administered Temozolomide Versus Adjuvant Temozolomide Alone in Newly-Diagnosed Glioblastoma. 2008.
Cita MLASher, David J., et al. The Added Value of Concurrently-Administered Temozolomide Versus Adjuvant Temozolomide Alone in Newly-Diagnosed Glioblastoma. 2008.
Atenció: Aquestes cites poden no estar 100% correctes.